Who owns March Biosciences?

March Biosciences is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2024.

When did 4Bio Partners acquire March Biosciences?

4Bio Partners acquired March Biosciences in 2024 (active for 2 years).

Home/Companies/Biotech/March Biosciences

March Biosciences

Biotech·

US·Active·2yr hold

March Biosciences is a biotech company, headquartered in US.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUS

SectorBiotech

StatusActive

US cell-therapy company developing CD5 CAR-T treatments for T-cell lymphoma; 4BIO Capital co-led its 2024 Series A financing.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings